Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.7 USD | +2.48% | +10.64% | +4.04% |
Business Summary
Number of employees: 160
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Endosomal Escape Vehicle Therapeutics
100.0
%
| 0 | nan % | 129 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 129 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 48 | 17-07-31 |
Kory Wentworth
DFI | Director of Finance/CFO | 45 | 20-10-31 |
Nathan Dowden
PSD | President | 54 | 19-11-03 |
Chief Tech/Sci/R&D Officer | 62 | 17-08-31 | |
Karla MacDonald
PRN | Corporate Officer/Principal | - | 21-05-31 |
Jared Cohen
LAW | General Counsel | - | 20-03-31 |
Kerry Robert
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Kim
BRD | Director/Board Member | 65 | 20-11-30 |
Mary Thistle
BRD | Director/Board Member | 64 | 21-05-03 |
Gina Chapman
BRD | Director/Board Member | 57 | 23-08-31 |
Dipal Doshi
CEO | Chief Executive Officer | 48 | 17-07-31 |
Kush Parmar
CHM | Chairman | 42 | 16-09-30 |
Bernhardt Zeiher
BRD | Director/Board Member | 60 | 23-04-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,783,451 | 28,141,674 ( 83.30 %) | 0 | 83.30 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.04% | 486M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- TRDA Stock
- Company Entrada Therapeutics, Inc.